Abstract:Almost the entire world, not only China, is currently experiencing the outbreak of a novel coronavirus that causes respiratory disease, severe pneumonia, and even death. The outbreak began in Wuhan, China, in December of 2019 and is currently still ongoing. This novel coronavirus is highly contagious and has resulted in a continuously increasing number of infections and deaths that have already surpassed the SARS-CoV outbreak that occurred in China between 2002 and 2003. It is now officially a pandemic, announced by WHO on the 11th of March. Currently, the 2019 novel coronavirus (SARS-CoV-2) can be identified by virus isolation or viral nucleic acid detection; however, false negatives associated with the nucleic acid detection provide a clinical challenge and thus make the imaging examination crucial. Imaging exams have been a main clinical diagnostic criteria for the 2019 novel coronavirus disease (COVID-19) in China. Imaging features of multiple patchy areas of ground glass opacity and consolidation predominately in the periphery of the lungs are characteristic manifestations on chest CT and extremely helpful in the early detection and diagnosis of this disease, which aids prompt diagnosis and the eventual control of this emerging global health emergency. Key Points • In December 2019, China, an outbreak of pneumonia caused by a novel, highly contagious coronavirus raised grave concerns and posed a huge threat to global public health. • Among the infected patients, characteristic findings on CT imaging include multiple, patchy, ground-glass opacity, crazy-paving pattern, and consolidation shadows, mainly distributed in the peripheral and subpleural areas of both lungs, which are very helpful for the frontline clinicians. • Imaging examination has become the indispensable means not only in the early detection and diagnosis but also in monitoring the clinical course, evaluating the disease severity, and may be presented as an important warning signal preceding the negative RT-PCR test results.

Coronavirus Disease 2019 (COVID-19): A Perspective from China

Current epidemiological and clinical features of COVID-19; a global perspective from China.

The epidemiology and clinical information about COVID-19

Current Status of Etiology, Epidemiology, Clinical Manifestations and Imagings for COVID-19

2019 Novel Coronavirus (2019-Ncov) and 2019-Ncov Pneumonia

A Novel Coronavirus 2019 Linked with Pneumonia in China: Current Status and Future Prospects

The role of imaging in 2019 novel coronavirus pneumonia (COVID-19)

Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): from Bench to Bedside

The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019

Clinical and Radiological Features of Patients with Coronavirus Disease 2019

Coronavirus Disease 2019 (COVID-19): Chest CT Characteristics Benefit to Early Disease Recognition and Patient Classification—a Single Center Experience

The Clinical and Radiological Manifestations in Coronavirus Disease 2019 with Negative Nucleic Acid Results.

Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China

Eleven Faces of Coronavirus Disease 2019

Coronavirus disease 2019 (COVID-19): current status and future perspectives

Guidance for the Management of Adult Patients with Coronavirus Disease 2019.

Chest CT--The Gatekeeper to COVID-19

CT findings of severe novel coronavirus disease (COVID-19): A case report of Heilongjiang Province, China

Clinical Characteristics of Coronavirus Disease 2019 in China

Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China

Coronavirus Disease 2019 (COVID-19): a Clinical Update